Crossmark

The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands

Crossref DOI link: https://doi.org/10.1186/s41687-024-00714-y

Published Online: 2024-03-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dhaenens, Britt A. E. http://orcid.org/0000-0003-0928-4049
van Dijk, Sarah A.

Taal, Walter

Noordhoek, D. Christine

Coffey, Anna

McKenna, Stephen P.

Oostenbrink, Rianne
License Information

Text and Data Mining valid from 2024-03-18

Version of Record valid from 2024-03-18
More Information

Article History

Received: 6 September 2023

Accepted: 12 March 2024

First Online: 18 March 2024

Declarations

:

: This study was approved by the local Institutional Review Board (IRB) of the Erasmus Medical Center, local identifier MEC-2021-0598. All participants provided written consent to participate.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below